High-dose 13.3mg/24h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use
Molinuevo, J.L., Cummings, J., Frölich, L., Galvin, J., Krahnke, T., Strohmaier, C.Volume:
333
Language:
english
Journal:
Journal of the Neurological Sciences
DOI:
10.1016/j.jns.2013.07.1280
Date:
October, 2013
File:
PDF, 62 KB
english, 2013